Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2000
05/17/2000EP1000033A1 Heterocyclic derivatives which inhibit factor xa
05/17/2000EP1000031A1 Vitronectin receptor antagonist
05/17/2000EP1000017A1 Il-8 receptor antagonists
05/17/2000EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0999834A1 Antithrombotic agents
05/17/2000EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253553A Substituted phenyl derivatives, their preparation and use
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1253501A IL-8 receptor antagonists
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1052481C Platelet activating factor antagonist and preparation thereof
05/16/2000US6063909 Preparation of factor IX
05/16/2000US6063624 Separating platelet-rich plasma from whole blood, separating platelets from plasma, resuspending said platelet concentrate in a hypertonic solution of sodium chloride or potassium chloride; for storage or transfusion
05/16/2000CA2053121C Pharmaceutical preparation based on lys-plasminogen
05/13/2000CA2289327A1 An anti-edema agent
05/11/2000WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
05/11/2000WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026227A1 Ldl related protein and uses thereof
05/11/2000WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors
05/11/2000WO2000026211A1 Thrombin inhibitors
05/11/2000WO2000026210A1 Thrombin inhibitors
05/11/2000WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2348734A1 Thrombin inhibitors
05/11/2000CA2348530A1 Thrombin inhibitors
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2317808A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/10/2000EP0999219A2 Novel heparin binding peptides
05/10/2000EP0998942A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
05/10/2000EP0998916A1 Medicinal compositions for application to mucosa
05/10/2000EP0998561A1 Trail receptor
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252726A Methods for treating vascular disorders
05/10/2000CN1252279A Soluble heme and its preparation process and hematic composite with it
05/10/2000CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them
05/10/2000CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060464 Compounds and pharmaceutical compositions containing them
05/09/2000US6060451 Thrombin inhibitors based on the amino acid sequence of hirudin
05/09/2000US6060300 Thrombin muteins as antidotes for thrombin inhibitors
05/09/2000US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2062340C Process for the industrial-scale preparation of a highly pure standardized human von willebrand factor concentrate appropriate for therapeutic use
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024893A2 Methods and compositions for the prevention and treatment of anemia
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024727A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME
05/04/2000WO2000024718A1 Serine protease inhibitor
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024261A1 Stromal cell use
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348770A1 Stromal cell use
05/04/2000CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000CA2346990A1 Serine protease inhibitor
05/04/2000CA2344606A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2342626A1 Substituted phenyl derivatives, their preparation and use
05/03/2000EP0997474A1 Antithrombotic agents
05/03/2000EP0997465A1 Azaindole derivatives and their use as antithrombotic agents
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997460A1 Benzothiophene compounds as antithrombotic agents and intermediates
05/03/2000EP0996721A2 Secreted proteins and polynucleotides encoding them
05/03/2000EP0996637A1 Recombinant protein c and protein s variants
05/03/2000EP0996621A1 Novel compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996462A1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000CN1252074A Stimulation of red blood cell production
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 671